DR.Med Richard Joosten SRL
DR.Med Richard Joosten reported total assets of 113,227 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 May 2026).
The score of DR.Med Richard Joosten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR.Med Richard Joosten's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 19,374 € | ||||
| Equity | 98,772 € | ||||
| Cash | 35,624 € | ||||
| EBITDA | 35,533 € | ||||
| Total assets | 113,227 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 May 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 07 Mar 2022
DR.Med Richard Joosten's financial analysis
- Solvency87.2%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR.Med Richard Joosten
DR.Med Richard Joosten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0869.627.467
- VAT number
- BE0869627467
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 25 Oct 2004
- Registered office
- 4700 Eupen
- Latest accounts
- 2025 · filed on 29 May 2026
- Activity
- Medical specialists activities (NACE 86220)
DR.Med Richard Joosten (SRL) has been based in Eupen since 2004, active in: medical specialists activities. For 2025, it reports a net profit of 19,374 € and equity of 98,772 €; its revenue is not published. Its solvency stands at 87.2%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR.Med Richard Joosten
Companies in the same business, of comparable size and area, outside its group.
- Remy de Stexhe Other publishing activities, except software publishing Villers-la-Ville · balance sheet 119,529 €
- Thuy-Vereecken Manufacture of other builders’ carpentry and joinery Sint-Gillis-Waas · balance sheet 113,281 €
- Lizon et Fils Machining of metals Tournai · balance sheet 113,323 €
- Bouwhandelgroep Lanaken · balance sheet 113,237 €
- Stratégie Masculine Anderlecht · balance sheet 113,214 €
- Centre Syndical Charleroi Charleroi · balance sheet 113,261 €
- Sarina Care Lessines · balance sheet 113,285 €
Frequently asked questions about DR.Med Richard Joosten
What is the revenue of DR.Med Richard Joosten?
DR.Med Richard Joosten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR.Med Richard Joosten?
In Belgium, the VAT number is the company number prefixed with BE: BE0869627467 for DR.Med Richard Joosten, if the company is VAT-registered. Its company number (CBE) is 0869.627.467.
Where is the registered office of DR.Med Richard Joosten?
According to the CBE register, the registered office of DR.Med Richard Joosten is in 4700 Eupen.
What is the equity of DR.Med Richard Joosten?
At the close of the 2025 financial year, the equity of DR.Med Richard Joosten amounts to 98,772 €, a solvency of 87.2% of total assets.
Who manages DR.Med Richard Joosten?
The register lists 1 active mandates at DR.Med Richard Joosten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR.Med Richard Joosten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →